PURPOSE: To compare retinal thickness (RT) measurement and segmentation performance of time domain (TD, Stratus) and spectral domain (SD) optical coherence tomography (OCT) devices (Cirrus, Spectralis) for imaging macular oedema (ME) secondary to branch retinal vein occlusion (BRVO). METHODS: In this study, 20 eyes of 20 consecutive patients with acute BRVO were included. A total of 18 unaffected fellow eyes served as control group. RT measurement was analysed in the five inner fields of the early-treatment diabetic retinopathy grid, and proportional segmentation errors were evaluated. RESULTS: Central millimetre thickness (CMT) showed a mean difference of -64, -74, and -18 μm (P < 0.001) in the control group and -31 μm (P=0.107), -92 μm (P<0.001), and -105 μm (P=0.016) in the BRVO group, between Stratus and Cirrus, between Stratus and Spectralis, and between Cirrus and Spectralis, respectively. Mean RT showed the highest variability between different devices in the area most intensively affected by BRVO-related ME. In eyes with BRVO, 14.6% of Spectralis, 20% of Stratus, and 36.6% of Cirrus scans demonstrated moderate and severe segmentation errors. CONCLUSION: RT measurement in eyes with BRVO, by TD and SD OCT, is compromised by a significant rate of segmentation errors. Deviations are most pronounced in the areas most severely affected by ME.
PURPOSE: To compare retinal thickness (RT) measurement and segmentation performance of time domain (TD, Stratus) and spectral domain (SD) optical coherence tomography (OCT) devices (Cirrus, Spectralis) for imaging macular oedema (ME) secondary to branch retinal vein occlusion (BRVO). METHODS: In this study, 20 eyes of 20 consecutive patients with acute BRVO were included. A total of 18 unaffected fellow eyes served as control group. RT measurement was analysed in the five inner fields of the early-treatment diabetic retinopathy grid, and proportional segmentation errors were evaluated. RESULTS: Central millimetre thickness (CMT) showed a mean difference of -64, -74, and -18 μm (P < 0.001) in the control group and -31 μm (P=0.107), -92 μm (P<0.001), and -105 μm (P=0.016) in the BRVO group, between Stratus and Cirrus, between Stratus and Spectralis, and between Cirrus and Spectralis, respectively. Mean RT showed the highest variability between different devices in the area most intensively affected by BRVO-related ME. In eyes with BRVO, 14.6% of Spectralis, 20% of Stratus, and 36.6% of Cirrus scans demonstrated moderate and severe segmentation errors. CONCLUSION: RT measurement in eyes with BRVO, by TD and SD OCT, is compromised by a significant rate of segmentation errors. Deviations are most pronounced in the areas most severely affected by ME.
Authors: Lelia A Paunescu; Joel S Schuman; Lori Lyn Price; Paul C Stark; Siobahn Beaton; Hiroshi Ishikawa; Gadi Wollstein; James G Fujimoto Journal: Invest Ophthalmol Vis Sci Date: 2004-06 Impact factor: 4.799
Authors: Srinivas R Sadda; Ziqiang Wu; Alexander C Walsh; Len Richine; Jessica Dougall; Richard Cortez; Laurie D LaBree Journal: Ophthalmology Date: 2006-01-10 Impact factor: 12.079
Authors: T C Kreutzer; C S Alge; A H Wolf; D Kook; J Burger; R Strauss; C Kunze; C Haritoglou; A Kampik; S Priglinger Journal: Br J Ophthalmol Date: 2008-01-22 Impact factor: 4.638
Authors: C Ahlers; C Simader; W Geitzenauer; G Stock; P Stetson; S Dastmalchi; U Schmidt-Erfurth Journal: Br J Ophthalmol Date: 2007-10-26 Impact factor: 4.638
Authors: Luis de Sisternes; Gowtham Jonna; Jason Moss; Michael F Marmor; Theodore Leng; Daniel L Rubin Journal: Biomed Opt Express Date: 2017-02-28 Impact factor: 3.732
Authors: Anant Agrawal; Jigesh Baxi; William Calhoun; Chieh-Li Chen; Hiroshi Ishikawa; Joel S Schuman; Gadi Wollstein; Daniel X Hammer Journal: Invest Ophthalmol Vis Sci Date: 2016-07-01 Impact factor: 4.799